Beneficial actions of hyaluronan (HA) on arthritic joints: Effects of molecular weight of HA on elasticity of cartilage matrix

Biorheology

Volumn 43, Issue 3-4, 2006, Pages 347-354

  Kato, Yukio ^a   Nakamura, Shigeo ^a   Nishimura, Masahiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Aggrecan; Cartilage; Elasticity; Hyaluronan; OA; RA

Indexed keywords

AGGRECAN; AGGRECANASE; CORTICOSTEROID; CYCLOOXYGENASE 2; CYTOKINE; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROSTAGLANDIN E2; RANTES; STROMELYSIN; SUVENYL; UROKINASE;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CARTILAGE MATRIX; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ELASTICITY; HUMAN; HUMEROSCAPULAR PERIARTHRITIS; KNEE OSTEOARTHRITIS; LIGHT SCATTERING; MOLECULAR WEIGHT; NONHUMAN; PAIN; RHEUMATOID ARTHRITIS; VISCOSITY;

ANIMALS; ARTHRITIS; CARTILAGE, ARTICULAR; ELASTICITY; HUMANS; HYALURONIC ACID; MOLECULAR WEIGHT; VISCOSITY;

EID: 33747138604     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. M.W. Holmes, M.T. Bayliss and H. Muir, Hyaluronic acid in human articular cartilage. Age-related changes in content and size, Biochem. J. 250 (1988), 435-441.
2. H. Kamada, K. Masuda, A.L. D'Souza, M.E. Lenz, D. Pietryla, L. Otten and E.J.-M.A. Thonar, Age-related differences in the accumulation and size of hyaluronan in alginate culture, Arch. Biochem. Biophys. 408 (2002), 192-199.
3. T. Kikuchi, H. Yamada and K. Fujikawa, Effects of high molecular weight hyaluronan on the distribtion and movement of proteoglycan around chondrocytes cultured in alginate beads, Osteoarthritis Cartilage 4 (1996), 99-110.
4. D. Lajeunesse, A. Delalandre, J. Martel-Pelletier and J.P. Pelletier, Bone 33 (2003), 703-710.
5. M. Nishimura, M. Kawata, W. Yan, A. Okamoto, H. Nishimura, Y. Ozaki, T. Hamada and Y. Kato, Quantitative analysis of the effects of hyaluronan and aggrecan concentration and hyaluronan size on the elasticity of hyaluronan-aggrecan solutions, Biorheology 41 (2004), 629-639.
6. M. Nishimura, W. Yan, Y. Mukudai, S. Nakamura, K. Nakamasu, M. Kawata, T. Kawamoto, M. Noshiro, T. Hamada and Y. Kato, Toe of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids, Biochim. Biophys. Acta 1380 (1998), 1-9.
7. M. Oka, T. Nakamura and T. Kitsuji, Effect of high molecular weight hyaluronic acid on joint lubrication (in Japanese), Nihon Riumach, Kansetu Geka, Gakkai-Zassi 12 (1993), 259-266.
8. M. Oka, T. Nakamura, Y. Matsusue, M. Akagi and M. Horiguchi, Effects of high-molecular weight hyaluronate on joint disorders (in Japanese), Seikei Saigai Geka 40 (1997), 77-84.
9. S. Sohen, K. Kikuchi, T. Nonaka and C. Hamanishi, Clinical and experimental evaluation of hyaluronic acid for rheumatoid arthritis (in Japanese), Clin. Rheumatol. 15 (2003), 70-75.
10. K. Tamoto, H. Nochi and Y. Tokumitsu, High molecular weight hyaluronic acids inhibit interleukin-1-induced prostaglandin E2 generation and prostaglandin E2-elicited cyclic AMP accumulation in human rheumatoid arthritic synovial cells, Japanese J. Rheum. 5 (1994), 227-236.
11. M. Tanaka, K. Fujii, M. Tsuji and T. Sawai, Autoimmune reaction to type II collagen and cartilage degeneration in MRL/Mp-lpr/lpr mouse, Rheumatol. Int. 24 (2004), 84-92.
12. S. Tanaka, M. Yamamoto, Y. Komatsubara, S. Sugawara, S. Soen, T. Matsubara, S. Kashiwazaki and M. Nakashima, Clinical study of high molecular hyaluronic acid (NRD101) on rheumatoid arthritis. A multi-center, joint phase III comparative study (in Japanese), Clin. Rheumatol. 5 (1994), 304-332.
13. M. Yamamoto, S. Sugawara, Y. Tsukamoto, M. Motegi, H. Iwata, J. Ryu, K. Takagishi and M. Nakashima, Clinical evaluation of high molecular weight sodium hyaluronate (NRD101) on osteoarthritis of the knee (in Japanese), Jpn. Pharmacol. Ther. 22 (1994), 4059-4087.
14. R. Yamamoto, S. Tabata, M. Mikasa, K. Takagishi and M. Nakashima, Phase III comparative clinical study of high molecular weight sodium hyaluronate (NRD101) with ARTZ® on periarthritis scapulohumeralis (in Japanese), Jpn. Pharmacol. Ther. 22 (1994), 4029-4057.